Photo AI
Question 10
Read the following passage. BRCA1 and BRCA2 are human genes that code for tumour suppressor proteins. Mutations in BRCA1 and BRCA2 can cause cancer. Specific inheri... show full transcript
Step 1
Answer
Mutations in the BRCA1 and BRCA2 genes can lead to a change in the DNA base sequence, which may result in an altered protein product or ineffective proteins. This can impact the genes' ability to suppress tumour formation effectively, causing uncontrolled cell division and increasing the risk of cancer.
Step 2
Answer
To screen for harmful mutations, DNA from saliva can be collected and amplified using PCR (Polymerase Chain Reaction). The DNA is then cut with restriction enzymes, and the resulting fragments are separated through gel electrophoresis. Labeled DNA probes specific to known harmful mutations can bind to the fragments to highlight any existing mutations.
Step 3
Answer
These drugs can bind to oestrogen receptors in breast cancer cells, preventing the actual hormone oestrogen from binding. This inhibition reduces the stimulation of cancer cell growth and division, inhibiting the proliferation of ER-positive breast cancer cells.
Step 4
Answer
Blood tests measuring prostate-specific antigen (PSA) levels may yield false positives, as elevated PSA levels can occur due to conditions other than prostate cancer, such as urinary infections or benign prostatic hyperplasia. Therefore, high PSA levels alone cannot confirm the presence of prostate cancer.
Step 5
Answer
Drugs that target the epigenetic modification processes can lead to decreased methylation of oncogenes and increased expression of tumour suppressor genes. For example, certain drugs can inhibit enzymes that add methyl groups to DNA, thus restoring the normal expression patterns of genes involved in cell cycle regulation and apoptosis, which may help in reversing tumorigenesis.
Report Improved Results
Recommend to friends
Students Supported
Questions answered